ADL
MRNA icon

Asset Dedication LLC’s Moderna MRNA Stock Holding History

Asset Dedication LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59K Hold
843
– – ﹤0.01% 475
2026
Q1 		$42.8K Hold
843
– – ﹤0.01% 497
2025
Q4 		$24.9K Hold
843
– – ﹤0.01% 625
2025
Q3 		$21.8K Sell
843
-2
-0.2% -$56 ﹤0.01% 662
2025
Q2 		$23.3K Sell
845
-268
-24% -$7.06K ﹤0.01% 663
2025
Q1 		$31.6K Buy
1,113
+163
+17% +$5.78K ﹤0.01% 558
2024
Q4 		$39.5K Sell
950
-68
-7% -$3.25K ﹤0.01% 517
2024
Q3 		$68K Hold
1,018
– – ﹤0.01% 461
2024
Q2 		$121K Buy
1,018
+300
+42% +$38K 0.01% 380
2024
Q1 		$76K Sell
718
-50
-7% -$5.04K 0.01% 396
2023
Q4 		$77K Hold
768
– – 0.01% 382
2023
Q3 		$79K Buy
768
+50
+7% +$5.58K 0.01% 386
2023
Q2 		$87K Hold
718
– – 0.01% 384
2023
Q1 		$110K Hold
718
– – 0.01% 353
2022
Q4 		$129K Hold
718
– – 0.01% 341
2022
Q3 		$85K Hold
718
– – 0.01% 357
2022
Q2 		$103K Sell
718
-40
-5% -$5.72K 0.02% 189
2022
Q1 		$131K Hold
758
– – 0.01% 333
2021
Q4 		$192K Sell
758
-2
-0.3% -$585 0.02% 281
2021
Q3 		$292K Buy
760
+42
+6% +$15.5K 0.04% 230
2021
Q2 		$169K Buy
718
+650
+956% +$116K 0.03% 277
2021
Q1 		$9K Sell
68
-77
-53% -$11.2K ﹤0.01% 516
2020
Q4 		$15K Buy
145
+77
+113% +$7.79K ﹤0.01% 498
2020
Q3 		$5K Hold
68
– – ﹤0.01% 600
2020
Q2 		$4K Buy
+68
New +$3.72K ﹤0.01% 549

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Asset Dedication LLC's MRNA Position: Q2 2026 in Review

Asset Dedication LLC held its Moderna (MRNA) position steady in Q2 2026 at 843 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Asset Dedication LLC first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $292K in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Asset Dedication LLC held 843 shares of Moderna worth $59K as of Q2 2026.
  • Asset Dedication LLC left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #475 holding.
  • Asset Dedication LLC first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Asset Dedication LLC's Moderna position peaked at $292K in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.